Evidence map›Paper›PMID 25980012›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Cutting Edge: Caspase-11 Limits the Response of CD8+ T Cells to Low-Abundance and Low-Affinity Antigens.

Tessa Bergsbaken, Michael J Bevan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Regulation, Activation and Function of Caspase-11 during Health and Disease.International journal of molecular sciences · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tessa BergsbakenDepartment of Immunology and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98109 bergst@uw.edu.
Michael J BevanDepartment of Immunology and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98109.
University of Washington · US

Funding

CYTOTOXIC RESPONSE TO HISTOCOMPATIBILITY ANTIGENSR01AI019335 · NIAID · UNIVERSITY OF WASHINGTON · PI BEVAN, MICHAEL J · 1985 to 2012
$4.4M
CYTOTOXIC RESPONSE TO HISTOCOMPATIBILITY ANTIGENSR37AI019335 · NIAID · UNIVERSITY OF WASHINGTON · PI BEVAN, MICHAEL J · 1988 to 1997
–
Howard Hughes Medical InstituteNIAID NIH HHS AI-19335NIAID NIH HHS R01 AI019335
6 · The paper itself

Abstract

Inflammatory caspases, including caspase-11, are upregulated in CD8(+) T cells after Ag-specific activation, but little is known about their function in T cells. We report that caspase-11-deficient (Casp11(-/-)) T cells proliferated more readily in response to low-affinity and low-abundance ligands both in vitro and in vivo due to an increased ability to signal through the TCR. In addition to increased numbers, Casp11(-/-) T cells had enhanced effector function compared with wild-type cells, including increased production of IL-2 and reduced expression of CD62L. Casp11(-/-) T cells specific for endogenous Ags were more readily deleted than wild-type cells. These data indicate that caspase-11 negatively regulates TCR signaling, possibly through its ability to regulate actin polymerization, and inhibiting its activity could enhance the expansion and function of low-affinity T cells.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsAntigensCaspasesCaspases, InitiatorCD8-Positive T-LymphocytesCell ProliferationImmunity, InnateInterleukin-2Listeria monocytogenesL-SelectinMiceMice, KnockoutOvalbuminReceptors, Antigen, T-CellSignal TransductionAntigensCasp4 protein, mouseCaspasesCaspases, InitiatorInterleukin-2L-SelectinOvalbuminReceptors, Antigen, T-Cell

Identifiers

PMID25980012
PMCPMC4475665
OpenAlexW1920216759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.